Bacteriophages Expressing Antimicrobial Peptides and Uses Thereof

The present invention is generally related to engineered bacteriophages expressing antimicrobial peptides or lytic enymes or fragments thereof for targeting a broad spectum of bacterial hosts, and for the long-term suppression of bacterial phage resistance for reducing bacterial infections. In some embodiments, bacteriophages express antimicrobial peptides or antimicrobial polypeptides (e.g. phage lytic enzymes) which are secreted from the host bacteria, or alternatively released upon lysis of the bacterial host cell. Aspects of the present invention also relate to the use of the engineered bacteriophages for the reduction of bacterial infections, both in a subject or for bioremediation purposes, in clinical settings and wound healing.

Attached files:


Patents:
WO 2,010,141,135

Inventor(s): COLLINS JAMES J [US]; KOERIS MICHAEL [US]; LU TIMOTHY KUAN-TA [US]; CHAU TANGUY MY [US]; STEPHANOPOULOS GREGORY

Type of Offer: Licensing



« More Biotech Patents

---